Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2017-04-14 / Cancer 2017 Aug;123(16):3061-3072Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2017-04-07 / J Hematol Oncol 2017 04;10(1):82Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2017-03-22 / J Transl Med 2017 03;15(1):64Immune and viral therapies for malignant primary brain tumors
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2017-03-05 / Expert Opin Biol Ther 2017 04;17(4):457-474A comprehensive review of immunotherapies in prostate cancer
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2017-03-02 / Crit. Rev. Oncol. Hematol. 2017 May;113:292-303Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2017-03-01 / Immunotherapy 2017 03;9(4):319-329Safety, efficacy, and immunogenicity of autologous tumor lysate-pulsed dendritic cell vaccination therapy after resection of stage IIA (T2N0, T3N0) esophageal cancer: A phase I trial.
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2017-02-23 / J Clin Oncol 35, 2017 (suppl 7S; abstract 153)Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
/in Dendritic Cells, International Publications, Prostate Cancer /von 2017-02-15 / Cytotherapy 2017 04;19(4):500-513A Dendritic Cell Vaccine Combined With Radiotherapy Activates the Specific Immune Response in Patients With Esophageal Cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2017-02-01 / J. Immunother. 2017 Feb/Mar;40(2):71-76
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de